Back to results
US 8,709,735 B2Granted
β-2 microglobulin as a biomarker for peripheral artery disease
AssigneesVermillion, Inc., The Board of Trustees of the Leland Stanford Junior University
InventorsJohn P. Cooke, Eric T. Fung, Elichiro Kimura
Life of this patent
Estimating the term…
Abstract
The present invention provides β2 microglobulin as a biomarker for qualifying or assessing peripheral artery disease in a subject.
Claims11
A method for qualifying peripheral artery disease status in a subject comprising:
- (a) measuring lysozyme in a biological sample from the subject;
- and
- (b) correlating the measurement or measurements with peripheral artery disease versus non-peripheral artery disease.
Dependencies are inferred from the claim text.